95 related articles for article (PubMed ID: 2623666)
1. Cytofluorometric analysis of nuclear DNA and cell protein in pancreatic carcinoma.
Yamauchi H; Ichinohasama R; Kakizaki K; Yamada Y; Tanaka N
Tohoku J Exp Med; 1989 Nov; 159(3):245-6. PubMed ID: 2623666
[TBL] [Abstract][Full Text] [Related]
2. Case report of hepatocellular carcinoma and cytofluorometric nuclear DNA ploidy.
Abdul Matin M; Kunitomo K; Komi N
Tokushima J Exp Med; 1992 Jun; 39(1-2):1-5. PubMed ID: 1329269
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous analysis of the patterns of nuclear DNA and cell protein contents in pancreatic carcinoma with reference to prognosis.
Kakizaki K; Yamauchi H
Tohoku J Exp Med; 1991 May; 164(1):51-8. PubMed ID: 1926146
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the malignant potentiality in superficial esophageal carcinoma by cytofluorometry of nuclear DNA and cellular protein contents--in relation to histopathologic findings and prognosis].
Nakamura T
Nihon Kyobu Geka Gakkai Zasshi; 1992 Feb; 40(2):242-52. PubMed ID: 1593164
[TBL] [Abstract][Full Text] [Related]
5. Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade.
Rugge M; Sonego F; Sessa F; Leandro G; Capella C; Sperti C; Pasquali C; Di Mario F; Pedrazzoli S; Ninfo V
Cancer; 1996 Feb; 77(3):459-66. PubMed ID: 8630952
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of analysis of DNA in pancreatic adenocarcinoma by flow cytometry.
Hyöty M; Visakorpi T; Kallioniemi OP; Mattila J; Laippala P; Nordback I
Eur J Surg; 1991 Oct; 157(10):595-600. PubMed ID: 1687251
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of nuclear DNA content in pancreatic carcinoma.
Alanen KA; Joensuu H; Klemi PJ; Nevalainen TJ
J Pathol; 1990 Apr; 160(4):313-20. PubMed ID: 2358969
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of DNA nuclear pattern as a prognostic determinant in resected pancreatic ductal adenocarcinoma.
Herrera MF; van Heerden JA; Katzmann JA; Weiland LH; Nagorney DM; Ilstrup D
Ann Surg; 1992 Feb; 215(2):120-4. PubMed ID: 1312318
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy in pancreatic neuroendocrine tumors.
Alanen KA; Joensuu H; Klemi PJ; Marin S; Alavaikko M; Nevalainen TJ
Am J Clin Pathol; 1990 Jun; 93(6):784-8. PubMed ID: 2346135
[TBL] [Abstract][Full Text] [Related]
11. [DNA-cytofluorometric, histopathological and immunohistochemical analyses of pancreatoduodenal cancers].
Horii A; Konishi E; Urata Y; Azumi Y; Kubo H; Yamagishi H; Oka T; Ashihara T
Gan To Kagaku Ryoho; 1993 Apr; 20(6):808-11. PubMed ID: 8489290
[TBL] [Abstract][Full Text] [Related]
12. Nuclear DNA distribution pattern of the parenchymal cells in adenocarcinomas of the pancreas and in chronic pancreatitis. A study of archival specimens using both image and flow cytometry.
Weger AR; Falkmer UG; Schwab G; Glaser K; Kemmler G; Bodner E; Auer GU; Mikuz G
Gastroenterology; 1990 Jul; 99(1):237-42. PubMed ID: 2188872
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of nuclear DNA content of duct cell carcinoma of the pancreas.
Yoshimura T; Manabe T; Imamura T; Imanishi K; Ohshio G; Yamabe H; Kitamura O; Matsumoto M; Ogasahara K; Takasan H
Cancer; 1992 Sep; 70(5):1069-74. PubMed ID: 1325268
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of DNA ploidy and cell-cycle analysis in pancreatic and periampullary carcinoma.
Jorba R; Fernández-Cruz L
Hepatogastroenterology; 1994 Oct; 41(5):507-8. PubMed ID: 7851864
[No Abstract] [Full Text] [Related]
15. Combined use of nuclear morphometry and DNA ploidy as prognostic indicators in nonresectable adenocarcinoma of the pancreas.
Linder S; Lindholm J; Falkmer U; Blåsjö M; Sundelin P; von Rosen A
Int J Pancreatol; 1995 Dec; 18(3):241-8. PubMed ID: 8708396
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in the nuclear DNA content of cells in carcinomas of the biliary tract and pancreas.
Suto T; Sasaki K; Sugai T; Kanno S; Saito K
Cancer; 1993 Nov; 72(10):2920-8. PubMed ID: 8221558
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative DNA measurements of ductal pancreatic cancers: comparison of the DNA content with histology, rate of survival, grading and staging].
Weger AR; Graf AH; Askensten U; Schwab G; Bodner E; Auer G; Mikuz G
Verh Dtsch Ges Pathol; 1987; 71():126-9. PubMed ID: 2830735
[No Abstract] [Full Text] [Related]
18. DNA content of diffusely infiltrative carcinomas in the stomach.
Hattori T; Hosokawa Y; Sugihara H; Fukuda M; Hamada S; Fujita S
Pathol Res Pract; 1985 Dec; 180(6):615-8. PubMed ID: 3831996
[TBL] [Abstract][Full Text] [Related]
19. DNA cytofluorometric analysis of benign and malignant nerve sheath tumors.
Tsuji Y; Kusuzaki K; Kuzuhara A; Murata H; Takeshita H; Hirata M; Hashiguchi S; Hirasawa Y; Ashihara T
Anticancer Res; 2000; 20(6C):4691-6. PubMed ID: 11205202
[TBL] [Abstract][Full Text] [Related]
20. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
al-Abadi H; Nagel R
Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
